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The role of Na+/H+ exchange in protein kinase C-mediated effects in platelets was investigated by studying the effect 
of removal of extracellular Na+ @la+]3 on the different responses induced by phorbol 1Zmyristate 13-acetate (PMA) 
and 1,2- dioctanoylglycerol (diQ. None of the responses tudied, namely, protein phosphorylation, translocation of en- 
zyme activity to the membrane fraction, potentiatory and inhibitory effects on platelet activation ([Ca’+]i, arachidonate 
and granule release) showed an absolute ‘dependence on [Na+L. With the exception of dense-granule r lease, which was 
clearly potentiated by the removal of ma+]. and showed a negative correlation with exchanger activity, the other effects 
of PMA and diCs were not affected by [Na+lc removal. It is concluded that Na+/H+ exchange is not essential for protein 
kinase C activation in platelets. 
Na+/H+ exchange; Platelet; Protein kinase C 
Recent studies in different cell systems have 
underlined the central role of the C2+ and 
phospholipid-dependent enzyme, protein kinase C 
(PKC) in the control of cellular function [ 11. These 
reports have described stimulatory as well as in- 
hibitory effects of PKC activators on a variety of 
cellular processes. Cell functions stimulated by 
PKC activation include secretory events [2-51, 
1 ,Zdiacylglycerol (DAG) formation [6], Na+/H+ 
exchange [7-lo], [Ca’+]i mobilisation [I 11, as well 
as cell differentiation and growth [ 12,131. Some of 
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these processes uch as secretion, DAG formation 
and [Ca’+]i mobilisation can also be inhibited by 
PKC activation [4,5,14-171, and it is believed that 
activation of the enzyme can, depending on the cell 
system and response involved, act as a dual 
regulator of cellular functions. There is some 
evid&ce to suggest hat the effects of PKC may in 
part, if not wholly, be mediated via Na+/H+ ex- 
change and the resulting elevation in intracellular 
pH, [pHIi. Thus, cell division,and growth induced 
by mitogens and PKC activators is believed to be 
at least partially dependent on exchanger-mediated 
elevations in [pH]i [9,10,18,19]. Additionally, in 
platelets, Na+/H+ exchange has been reported to 
bls responsible for the effects of PKC on [Ca’+]i 
mobilisation [20]. Our continuing interest in the 
elucidation of the role of PKC as a stimulatory vs 
inhibitory signal in platelet activation led us to ex- 
amine in detail the role of the Na+/H+ mechanism 
in PKC mediated effects in platelets. Using the 
PKC activators, phorbol 12Lmyristate 13-acetate 
(PMA) and 1,2-dioctanoylglycerol (dice), we 
report here that Na+/H+ exchange is not necessary 
1. INTRODUCTION 
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for any of the effects mediated by PKC activation 
in platelets. 
2. EXPERIMENTAL 
PMA and quin-2 ester were purchased from Sigma 
(England); DiCs and bis(carboxyethyl)carboxyfluorescin 
(BCECF) from Novabiochem (UK) and Calbiochem (UK), 
respectively; and all radiochemicals and ,&thromboglobulin 
assay kits from Amersham (England). 
2.1. Preparation of washed platelet suspensions 
Washed platelet suspensions resuspended in a pH 7.4 buffer 
(buffer B) composed of 10 mM Hepes, 5 mM KCI, 1 mM 
MgS04, 1 mM CaC12, 0.35% BSA, 0.09% glucose, 0.05 U/ml 
hirudin and 145 mM NaC or choline+ as the chloride salt were 
prepared from titrated platelet-rich plasma foilowing a 
centrifugation-wash step in a pH 6.5 buffer (buffer A), com- 
prising 35 mM citric acid, 5 mM KCl, 0.5 mM CaCla, 0.35% 
bovine serum albumin (BSA), 0.09% glucose, 0.05 U/ml 
hirudin and 103 mM Na+ or choline as described [17]. Loading 
of platelets with quin-2 and [t4C]5HT was carried out by in- 
cubating 20pM quin-2 ester or 1 &i/ml [r4C]5HT with PRP 
for 30 min at 37°C. For experiments on [pH]i determinations, 
protein phosphorylation and arachidonate release, a concen- 
trated platelet suspension (10’ platelets/ml) in buffer A (minus 
Ca2+ and BSA for the phosphorylation experiments) containing 
Na+ was incubated with 5 CM BCECF ester for 45 min, 
0.25 mCi/ml carrier-free [“Plorthophosphate for 90 min, or 
0.75 &i/ml [3H]arachidonic acid for 90 min at 37°C following 
which platelets were washed by centrifugation and resuspended 
in buffer B of the appropriate ionic composition. For all ex- 
periments, washed platelets were pre-treated with indomethacin 
(10 PM) to avoid effects of endogenously formed thromboxane 
A2. 
2.2. Measurement of [“C]sNT. ?HJarachidonate and 
,&thromboglobulin release and “P-protein phos- 
phoryiation 
[r4C]5HT and [‘Hlarachidonate release were evaluated 3 min 
after addition of the appropriate agonist by counting platelet 
supernatants for released radioactivity [ 171. ,& 
Thromboglobulin (f?-TG) levels in platelet supernatants were 
measured by radioimmunoassay using commercially available 
kits, Protein phosphorylation following addition of PMA or 
diCs was monitored in 32P-labelled platelets by SDS- 
polyacrylamide gel electrophoresis and autoradiography [ 171. 
2.3. Measurement Of JCOr’Ji and [pHJ/i 
Fluorescence measurements on quin-2 and BCECF-loaded 
platelets (unstirred) and calibration of the quin-2 and BCECF 
signals to calculate [Ca*+]i and [pH]r were carried out essential- 
ly as in [21]. Absolute [pH]i values were determined by using the 
nigericin/KCl method to correct the values obtained from lys- 
ing platelet suspensions (at external pH 6.0-8.0) with digitonin. 
2.4. Measurements of protein kinase C activity in platelet 
cytosol and membrane fractions 
Platelets (0.8-l x 10’ in 320 ~1 buffer B, containing Naf or 
148 
choline), incubated with PMA (160 nM) without stirring for 
1-15 min at 37”C, were collected by centrifugation (1500 x g, 
5 min, 4°C) by discarding the supernatant, resuspension of the 
pellet in 100 ,ul of 20 mM Tris-HCl (pH 7.4) containing 2 mM 
EDTA, 0.5 mM EGTA, 50 ,ug/ml leupeptin, 1 mM 
phenylsulphonyl fluoride and 0.1% &mercaptoethanol (buffer 
C) and subsequent sonication (4 x 10 s bursts). The suspension 
was centrifuged at 35000 x g for 60 min at 2°C. The pellet, 
following brief sonication (4 x 5 s bursts) in buffer C and the 
cytosolic supernatant, were subjected to chromatography on 
DEAE-cellulose (DE52, Whatman) equilibrated with buffer C 
and the enzyme eluted with 300 /tl buffer C containing 0.12 M 
NaCl. PKC activity in the eluates from the membrane and 
cytosol fractions was assayed immediately by measuring “P in- 
corporation into histone substrate using [y-“P]ATP as the 
phosphate donor [22]. 
3. RESULTS 
3.1. Effect of [Na’]= removal on diC8/ 
PMA-induced aggregation, 5HT and 
,& TG secretion 
Platelet aggregation and 5HT secretion induced 
by dies and PMA were significantly enhanced 
upon substitution of [Na+le with choline+ (fig.1, 
diCg NH 
I I 
’ t a 113.4 t 2.11 op b 139.0 t 2.01# 1 min a 149.4 f 2.81* 
+- 
Na + Choline ’ 
Fig. 1. DiCs (60 ,uM)-induced platelet aggregation, [‘%]5HT 
secretion and [pH]i changes in Na+ and choline+ buffer. 
(Upper) Aggregation traces showing the increase in light 
transmission after addition of diCs; values in parentheses beside 
each trace represent Vo [14C]5HT released 3 min after diCs 
addition (means f SE of 12 determinations from 4 
experiments). (Lower) Fluorescence changes representing the 
[pH]i induced by diCs in BCECF-loaded platelets. In both 
panels, traces a and b represent he respective ffects of diCs 
alone in Na’ or choline+ buffer and of pre-incubating platelets 
with NH&l (10 mM) for 1 min before diCs addition. * p < 
0.01 vs diCs control in Na+ buffer (Student’s t-test for unpaired 
data). # p < 0.01 vs diCs control in choline+ buffer. 
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Table 1 
DiCs and PMA-induced granule secretion in platelets 
resuspended in Naf and choline+ buffer 
Release (@IO) (means sf SE) 
[14C]5HT /3TG (C1g/ml) 
DiCs (6OpM) Na+ 13.4 f 2.1 0.35 f 0.10 
choline+ 49.4 zt 2.8” 0.63 f 0.21 
PMA (16 nM) Na+ 2.8 f 0.7 1.2 f 0.24 
choline+ 12.7 f 1.8’ 1.4 f 0.29 
*p c 0.01 vs release in Na+ buffer 
[r4C]5HT and flG secretion was measured in platelet 
supernatants 3 min after addition of diCs (6OpM) or PMA 
(16 nM). The release in resting platelets was subtracted from the 
values shown 
table 1). This was accompanied by the absence of 
a [pH]i rise and cytoplasmic acidification (0.05 pH 
units below resting) in choline+ buffer. Pre- 
a b c d 
45kd 
20kd 
Fig.2. DiCs-induced protein phosphorylation in Na+ and 
choline+ buffer. Autoradiograph of a dried gel (from an 
experiment in which 20 kDa protein labelling was enhanced in 
choline+ buffer) showing changes in “P labelling of the 45 and 
20 kDa substrates. Lanes: (a,b) resting and diCs @OpM)- 
treated platelets (3 min) respectively, in Na+ buffer; (c,d) as for 
a,b in choline+ buffer. 
treatment of platelets with NH&l (10 mM) 
elevated the [pH]i (0.01-0.2 pH units above 
resting) in Na+ and choline+ buffer and partially 
reversed the potentiated secretory response to diCs 
in choline+ buffer (fig.1). In contrast to 5HT secre- 
tion, ,&TG secretion induced by diCs and PMA 
was unaffected by removal of [Na+lc (table 1). 
3.2. Effect of [Na’je removal on protein 
phosphoryiation and translocation of PKC 
activity induced by diCa/PMA 
Phosphorylation states of the various proteins in 
resting platelets were not significantly different in 
Na+ vs choline+ buffer. In three out of five ex- 
periments, diCs and PMA-induced phosphoryla- 
tion of the major 45 and 20 kDa substrates was not 
A. CYTOSOL 
MINUTES PMA EXPOSURE 
Fig.3. PMA-induced translocation of protein kinase C activity 
in platelets resuspended in Na+ and choline+ buffer. Unstirred 
platelets resuspended in Na+ (0) or choline+ (0) buffer were 
treated with PMA (160 nM) for 1, 5 or 15 min following which 
PKC activity in the membrane and cytosol fractions was 
assayed. Enzyme activity in resting platelets is shown as zero 
time. 
149 
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significantly different in Na+ vs choline+ buffer 
(fig.2), although in two other experiments, the 
20 kDa substrate showed a greater increase in J2P 
labelling in choline+ buffer upon diCs addition. 
Fig.3 shows that the extent and time course of 
PMA-induced translocation of PKC activity from 
cytosol to membrane were virtually identical in 
Na+ and choline+ buffer. In resting platelets, the 
distribution of enzyme activity in cytosol vs mem- 
brane was approx. 80 vs 20%, respectively, in both 
buffers, and this changed to an approximately 
equal distribution of PKC activity in cytosol and 
membrane 1 min after addition of PMA. ,This was 
maintained for up to 5 min after PMA addition; 
thereafter, a small increase (10%) in membrane- 
bound enzyme activity was observed in both 
buffers. 
3.3. Effect of [Na+je removal on potentiatoryl- 
inhibitory effects of PMA/diG on receptor- 
mediated responses 
Our previous studies [17] have shown that PMA 
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and diCs have potentiatory effects on collagen- 
induced arachidonate release with incubation times 
l-5 min. Substitution of [Na+le with choline+ 
reduced the extent of collagen (20 pg/ml)-induced 
arachidonate release but did not affect its enhance- 
ment by PMA (increase from 6.11 to 8.7% in Na+ 
buffer; increase from 4.04 to 7.04% in choline+ 
buffer, with a 5 min pre-incubation of 16 nM 
PMA before addition of collagen; p < 0.01 in both 
cases). Fig.4 demonstrates that although the extent 
of thrombin (0.08 U/ml)-induced [Ca”]i eleva- 
tions was slightly different in Na+ vs choline+ buf- 
fer, the inhibition of this response by diCs was 
similar in both buffer systems (75.5 vs 80% inhibi- 
tion in’Na+ vs choline+ buffer). DiCs alone did not 
change resting [Ca*+]i n Na+ or choline+ buffer. 
4. DISCUSSION 
A number of recent studies [7-lo] have describ- 
ed stimulatory effects of PKC activators on the 
Na+/H+ exchange mechanism, and it has been 
I\ 
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DICs T T 
DIG,, CHOL-INE+ 
Fii.4. Effect of diCs (60 PM) on thrombin (0.08 U/ml)-induced [Ca’+}t mobilisation in quin-2-loaded washed platelets resuspended 
in Na+ or oholine+ buffer. DiCs was added 2 min before thrombin or at the peak ‘of the thrombin-induced {Cas+]r rise. Experiments 
were carried out with platelets resuspended in Naf and choline+ buffer (as these were different batches of platelets, the scales for the 
[Ca’+]i concentrations are different). 
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suggested that receptor-mediated exchanger activi- 
ty is due partially or totally to PKC activation by 
endogenously formed diacylglycerol. The increase 
in [pH]i caused by Na+ entering the cell has been 
described as an important mediator of the effects 
caused by PKC and/or receptor activation, name- 
ly, cell differentiation and proliferation 
[9,10,18,19] and [Ca*+]i mobilisation [20]. AS PKC 
is an important signalling system in platelets, exer- 
ting positive and negative control over different 
platelet responses, and since activation of the en- 
zyme leads to Na+/H+ exchange in platelets, we 
considered it vital to examine the role of Na+/H+ 
exchange in PKC activation, as well as responses 
mediated by activation of this enzyme in platelets. 
Using two activators of the enzyme, PMA and 
diCs, we have been able to demonstrate that 
neither the activation of PKC nor the effects due 
to enzyme activation in platelets have a 
dependence on Na+/H+ exchange. In a previous 
study that addressed the role of the exchanger in 
PKC-mediated effects in platelets, namely, Ca*+ 
mobilisation [20], the authors concluded that PKC 
enhances Ca*+ mobilisation by activating Na+/H+ 
exchange. Our view of this study is that the authors 
not only had insufficient evidence from which to 
draw their conclusion, but also failed to select the 
appropriate response to study. This is because their 
experiments involved the use of trifluoperazine 
and sphingosine as PKC inhibitors, which in a 
number of recent studies, including ours [23-251, 
have proved to be weak inhibitors of the enzyme 
with many undesirable ‘side-effects’ (on mem- 
brane stability/integrity, etc.), such that we regard 
them to be unsuitable reagents in this respect. Fur- 
thermore, there is no evidence implicating PKC as 
a positive modulator of Ca*+ mobilisation in 
platelets; rather, some studies [17,26,27] have con- 
vincingly shown PKC to be an inhibitor of 
receptor-mediated Ca*+ mobilisation in platelets. 
It is difficult therefore to see how PKC can 
enhance Ca*+ mobilisation via Na+/H+ exchange, 
and it is our view, as judged from the present 
results, that none of the effects actually mediated 
by PKC activation in platelets are dependent on 
Na+/H+ exchange. The only effect that was clearly 
altered by [Na+le removal was 5HT secretion. This 
process, contrary to earlier views on the impor- 
tance of exchanger activity for PKC activation, 
was enhanced by [Na+le removal. As the poten- 
tiated secretory response was at least partially 
reversed by addition of NH&l, we conclude that 
[pH]i elevation via Na+/H+ exchange is inhibitory 
to platelet dense-granule secretion. Interestingly, 
our results suggest that a-granule secretion may 
not be controlled in this way by Na+/H+ exchange. 
Regarding the mechanism underlying the in- 
creased secretion of 5HT in the absence of [Na+le, 
it is unlikely that 45 kDa protein phosphorylation 
and [Ca*+]i are controlling factors, as these func- 
tions, unlike 5HT secretion, were unaffected by 
PIa% removal. However, the increased 
phosphorylation of the 20 kDa protein seen in 
some experiments in the absence of [Na+le may be 
responsible for the increase in secretion and fur- 
ther studies assessing the contractile state of 
diCs/PMA-treated platelets in the absence of 
[Na+le may shed some light on this issue. 
In conclusion, although Na+/H+ exchange may 
be an important positive modulator of receptor- 
mediated Ca*+ mobilisation [28] as suggested 
earlier, the present study suggests that exchanger 
activation and elevations in [pH]i are not necessary 
for PKC activation or the effects mediated by ac- 
tivation of this enzyme in platelets. Clearly the 
platelet must represent a cell system in which, far 
from Na+/H+ exchange being the mediator of the 
effects of PKC, the two signalling systems affect 
cellular processes independently, and in some 
cases, such as Ca*+ mobilisation and 5HT secre- 
tion, have opposing effects on the same response. 
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